财主 发表于 2025-3-23 10:12:51

http://reply.papertrans.cn/3/229/22828/22828-11.png

欢腾 发表于 2025-3-23 15:29:26

Submitted on: 26 November 2007.
Revised on: 17 December 2007.
Accepted on: 28 December 2007.
Nephrologie & Therapeutique

现任者 发表于 2025-3-23 18:38:07

http://reply.papertrans.cn/3/229/22828/22828-13.png

联想 发表于 2025-3-24 01:52:35

Submitted on: 03 May 2001.
Revised on: 12 May 2001.
Accepted on: 06 June 2001.
Nephrologie & Therapeutique---JOHN LIBBEY EUROTEXT LTD

不如乐死去 发表于 2025-3-24 02:31:39

http://reply.papertrans.cn/3/229/22828/22828-15.png

Amendment 发表于 2025-3-24 08:20:16

Submitted on: 03 April 2003.
Revised on: 30 April 2003.
Accepted on: 06 May 2003.
Nephrologie & Therapeutique---JOHN LIBBEY EUROTEXT LTD

贫穷地活 发表于 2025-3-24 10:55:46

Submitted on: 01 April 2011.
Revised on: 26 April 2011.
Accepted on: 18 May 2011.
Nephrologie & Therapeutique

口味 发表于 2025-3-24 17:07:21

http://reply.papertrans.cn/3/229/22828/22828-18.png

宣誓书 发表于 2025-3-24 22:07:03

http://reply.papertrans.cn/3/229/22828/22828-19.png

食道 发表于 2025-3-25 01:51:27

http://reply.papertrans.cn/3/229/22828/22828-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊Nephrologie & Therapeutique 2024/2025影响因子:0.761 (NEPHROL THER) (1769-7255). (UROLOGY & NEPHROLOGY)(泌尿科和肾病学)Scienc